88 related articles for article (PubMed ID: 1327439)
1. [Immunohistochemical study of transferrin receptor expression in hepatocellular carcinoma].
Lin J
Zhonghua Yi Xue Za Zhi; 1992 Feb; 72(2):86-7, 128. PubMed ID: 1327439
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis of hepatocellular carcinoma using chicken anti-monoclonal antibody--as tumor marker on the heterophilic hanganutziu-deicher antigen].
Koda T; Shimosakoda T; Nishinaka S; Asaoka H; Nakaba H; Tamura I; Matsuda H
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2771-7. PubMed ID: 7993113
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical demonstration of transferrin receptor 1 and 2 in human hepatocellular carcinoma tissue.
Sakurai K; Sohda T; Ueda S; Tanaka T; Hirano G; Yokoyama K; Morihara D; Aanan A; Takeyama Y; Irie M; Iwata K; Syakado S; Noritomiz T; Yamashita Y; Sakisaka S
Hepatogastroenterology; 2014; 61(130):426-30. PubMed ID: 24901155
[TBL] [Abstract][Full Text] [Related]
4. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
[TBL] [Abstract][Full Text] [Related]
6. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T
Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663
[TBL] [Abstract][Full Text] [Related]
7. Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target.
Ito H; Funahashi S; Yamauchi N; Shibahara J; Midorikawa Y; Kawai S; Kinoshita Y; Watanabe A; Hippo Y; Ohtomo T; Iwanari H; Nakajima A; Makuuchi M; Fukayama M; Hirata Y; Hamakubo T; Kodama T; Tsuchiya M; Aburatani H
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3257-64. PubMed ID: 16740745
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma.
Park KS; Kim H; Kim NG; Cho SY; Choi KH; Seong JK; Paik YK
Hepatology; 2002 Jun; 35(6):1459-66. PubMed ID: 12029631
[TBL] [Abstract][Full Text] [Related]
9. Markers for hepatocellular carcinoma.
Wu AH; Sell S
Immunol Ser; 1990; 53():403-22. PubMed ID: 1713067
[TBL] [Abstract][Full Text] [Related]
10. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.
Hsu HC; Cheng W; Lai PL
Cancer Res; 1997 Nov; 57(22):5179-84. PubMed ID: 9371521
[TBL] [Abstract][Full Text] [Related]
11. Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma.
Tang W; Miki K; Kokudo N; Sugawara Y; Imamura H; Minagawa M; Yuan LW; Ohnishi S; Makuuchi M
Int J Oncol; 2003 May; 22(5):969-75. PubMed ID: 12684661
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical demonstration of alpha-fetoprotein in small hepatocellular carcinoma.
Sato K; Tanaka M; Kusaba T; Fukuda H; Tanikawa K
Oncol Rep; 1998; 5(2):355-8. PubMed ID: 9468556
[TBL] [Abstract][Full Text] [Related]
13. A new tumor-associated antigen useful for serodiagnosis of hepatocellular carcinoma, defined by monoclonal antibody KM-2.
Kumagai Y; Chiba J; Sata T; Ohtaki S; Mitamura K
Cancer Res; 1992 Sep; 52(18):4987-94. PubMed ID: 1381274
[TBL] [Abstract][Full Text] [Related]
14. [Studies on immunohistochemical localization and immunotargeting of monoclonal antibody against human hepatocellular carcinoma].
Ji YY
Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):335-8. PubMed ID: 8174475
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
Yang DC; Jiang XP; Elliott RL; Head JF
Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
[TBL] [Abstract][Full Text] [Related]
16. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas.
Ryschich E; Huszty G; Knaebel HP; Hartel M; Büchler MW; Schmidt J
Eur J Cancer; 2004 Jun; 40(9):1418-22. PubMed ID: 15177502
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of protein induced by vitamin K absence or antagonist II in hepatocellular carcinoma.
Ajisaka H; Shimizu K; Miwa K
J Surg Oncol; 2003 Oct; 84(2):89-93. PubMed ID: 14502782
[TBL] [Abstract][Full Text] [Related]
18. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
19. Alpha-fetoprotein in hepatocellular carcinoma: a serological and histochemical study in Malaysian patients.
Yap SF; Peh SC
Malays J Pathol; 1991 Dec; 13(2):115-8. PubMed ID: 1726642
[TBL] [Abstract][Full Text] [Related]
20. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
Lau SK; Prakash S; Geller SA; Alsabeh R
Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]